EUVIMEDEUVIMED entdecken
Editorial

Proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) and clinical outcomes in patients with end‐stage renal disease

Johann Auer iD, Lisa Auer

European Journal of Clinical Investigation · 2024

DOI: 10.1111/eci.14262 ↗

Kurz gefasst

Editorial in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Johann Auer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Intensive Care, St Josef Hospital, Braunau, Austria. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Proprotein Convertase 9. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Failure, ChronicProprotein Convertase 9AgedFemaleHumansMaleMiddle AgedAntibodies, Monoclonal, HumanizedAnticholesteremic AgentsCholesterol, LDLPCSK9 InhibitorsRenal Dialysis

Substanzen

alirocumabAntibodies, Monoclonal, HumanizedAnticholesteremic AgentsCholesterol, LDLevolocumabPCSK9 InhibitorsPCSK9 protein, humanProprotein Convertase 9

Autor:innen und Institutionen

  • Department of Cardiology and Intensive Care, St Josef Hospital, Braunau, Austria.
  • Department of Cardiology and Intensive Care, Kepler University Hospital, Linz, Austria.
  • Paracelsus Medical University, Salzburg, Austria.
  • Department of Experimental Cardiology, Medical University of Graz, Austria.

ORCID-Profile: Johann Auer

Zitieren

APA

Auer, J., & Auer, L. (2024). Proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) and clinical outcomes in patients with end‐stage renal disease. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14262

Vancouver

Auer J, Auer L. Proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) and clinical outcomes in patients with end‐stage renal disease. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14262

BibTeX
@article{Auer2024,
  author = {Auer, Johann and Auer, Lisa},
  title = {Proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) and clinical outcomes in patients with end‐stage renal disease},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1111/eci.14262}
}
Kostenlos starten →